专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011112893A9 COMPOSITIONS FOR AMELIORATING CELL PROLIFERATIVE DISORDERS AND METHODS OF MAKING AND USING THEM 审中-公开
标题翻译：用于改善细胞增殖性疾病的组合物及其制备和使用它们的方法
公开(公告)号：WO2011112893A9
公开(公告)日：2011-11-10
申请号：PCT/US2011028029
申请日：2011-03-11
申请人： UNIV CALIFORNIA , GERWICK WILLIAM H , TIDGEWELL KEVIN , VALERIOTE FRED
发明人： GERWICK WILLIAM H , TIDGEWELL KEVIN , VALERIOTE FRED
IPC分类号： A61K31/427 , A61K9/08 , A61K9/20 , A61K31/426 , A61P25/00 , A61P29/00
CPC分类号： C07D513/18 , C07D513/08
摘要： In alternative embodiments, the invention provides apratoxin F and apratoxin G compounds, which include apratoxin F and apratoxin G stereoisomers, derivatives and analogs compositions and methods. In alternative embodiments, the invention provides pharmaceutical compositions and formulations comprising apratoxin F (compound 6 of Figure 1) and apratoxin G (compound 7 of Figure 1) and their stereoisomers, derivatives and analogs. In alternative embodiments, pharmaceutical compositions and formulations of the invention are administered in an amount sufficient to treat, prevent and/or ameliorate a disease or condition that can be ameliorated by decreasing or inhibiting cell growth, e.g., pathological, uncontrolled or unwanted cell growth, e.g., a cancer or a metastases, or any disease or condition (e.g., allergy) or infection having a hyperproliferative cell growth component.
摘要翻译：在替代实施方案中，本发明提供了包括阿曲毒素F和阿曲毒素G立体异构体，衍生物和类似物组合物和方法的阿曲毒素F和阿曲毒素G化合物。在替代实施方案中，本发明提供了药物组合物和制剂，其包含阿曲毒素F（图1的化合物6）和阿曲毒素G（图1的化合物7）及其立体异构体，衍生物和类似物。在替代实施方案中，本发明的药物组合物和制剂以足以治疗，预防和/或改善可通过减少或抑制细胞生长而改善的疾病或病症的量施用，例如病理学，不受控制或不期望的细胞生长，例如癌症或转移瘤，或任何疾病或病症（例如过敏）或具有过度增殖细胞生长成分的感染。

2. 发明申请

WO2011112893A3 COMPOSITIONS FOR AMELIORATING CELL PROLIFERATIVE DISORDERS AND METHODS OF MAKING AND USING THEM 审中-公开
标题翻译：用于改善细胞增殖性疾病的组合物及其制备和使用它们的方法
公开(公告)号：WO2011112893A3
公开(公告)日：2012-03-15
申请号：PCT/US2011028029
申请日：2011-03-11
申请人： UNIV CALIFORNIA , GERWICK WILLIAM H , TIDGEWELL KEVIN , VALERIOTE FRED
发明人： GERWICK WILLIAM H , TIDGEWELL KEVIN , VALERIOTE FRED
IPC分类号： A61K31/427 , A61K9/08 , A61K9/20 , A61K31/426 , A61P25/00 , A61P29/00
CPC分类号： C07D513/18 , C07D513/08
摘要： In alternative embodiments, the invention provides apratoxin F and apratoxin G compounds, which include apratoxin F and apratoxin G stereoisomers, derivatives and analogs compositions and methods. In alternative embodiments, the invention provides pharmaceutical compositions and formulations comprising apratoxin F (compound 6 of Figure 1) and apratoxin G (compound 7 of Figure 1) and their stereoisomers, derivatives and analogs. In alternative embodiments, pharmaceutical compositions and formulations of the invention are administered in an amount sufficient to treat, prevent and/or ameliorate a disease or condition that can be ameliorated by decreasing or inhibiting cell growth, e.g., pathological, uncontrolled or unwanted cell growth, e.g., a cancer or a metastases, or any disease or condition (e.g., allergy) or infection having a hyperproliferative cell growth component.
摘要翻译：在替代实施方案中，本发明提供了包括阿曲毒素F和阿曲毒素G立体异构体，衍生物和类似物组合物和方法的阿曲毒素F和阿曲毒素G化合物。在替代实施方案中，本发明提供药物组合物和制剂，其包含阿曲马毒素F（图1的化合物6）和阿曲毒素G（图1的化合物7）及其立体异构体，衍生物和类似物。在替代实施方案中，本发明的药物组合物和制剂以足以治疗，预防和/或改善可以通过减少或抑制细胞生长（例如病理，不受控制或不期望的细胞生长）而改善的疾病或病症的量施用，例如癌症或转移瘤，或任何疾病或病症（例如过敏）或具有过度增殖细胞生长成分的感染。

3. 发明申请

WO2011112893A2 COMPOSITIONS FOR AMELIORATING CELL PROLIFERATIVE DISORDERS AND METHODS OF MAKING AND USING THEM 审中-公开
标题翻译：用于美容细胞增殖性疾病的组合物及其制备和使用方法
公开(公告)号：WO2011112893A2
公开(公告)日：2011-09-15
申请号：PCT/US2011/028029
申请日：2011-03-11
申请人： THE REGENTS OF THE UNIVERSITY OF CALIFORNIA , GERWICK, William, H. , TIDGEWELL, Kevin , VALERIOTE, Fred
发明人： GERWICK, William, H. , TIDGEWELL, Kevin , VALERIOTE, Fred
IPC分类号： A61K31/427 , A61K31/426 , A61K9/20 , A61K9/08 , A61P29/00 , A61P25/00
CPC分类号： C07D513/18 , C07D513/08
摘要： In alternative embodiments, the invention provides apratoxin F and apratoxin G compounds, which include apratoxin F and apratoxin G stereoisomers, derivatives and analogs compositions and methods. In alternative embodiments, the invention provides pharmaceutical compositions and formulations comprising apratoxin F (compound 6 of Figure 1) and apratoxin G (compound 7 of Figure 1) and their stereoisomers, derivatives and analogs. In alternative embodiments, pharmaceutical compositions and formulations of the invention are administered in an amount sufficient to treat, prevent and/or ameliorate a disease or condition that can be ameliorated by decreasing or inhibiting cell growth, e.g., pathological, uncontrolled or unwanted cell growth, e.g., a cancer or a metastases, or any disease or condition (e.g., allergy) or infection having a hyperproliferative cell growth component.
摘要翻译：在替代实施方案中，本发明提供了包括apratoxin F和apratoxin G立体异构体，衍生物和类似物组合物和方法的apratoxin F和apratoxin G化合物。在可选的实施方案中，本发明提供了包含apratoxin F（图1的化合物6）和apratoxin G（图1的化合物7）及其立体异构体，衍生物和类似物的药物组合物和制剂。在替代实施方案中，本发明的药物组合物和制剂以足以治疗，预防和/或缓解可通过减少或抑制细胞生长（例如病理性，不受控或不需要的细胞生长）而改善的疾病或病症的量施用，例如癌症或转移瘤或具有过度增殖性细胞生长成分的任何疾病或病症（例如变态反应）或感染。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式